HBsAg was assayed using a chemiluminescent immunoassay kit (Architect, HBsAg QT, Dainabot, Tokyo, Japan).
Estradiol concentrations were measured from rat serum by commercially available kit (Architect Estradiol, Abbott, Ireland) using chemiluminescent microparticle immunoassay technology.
Quantitative analysis of anti-HBs in a serum sample was further performed using a microparticle immunoassay kit (Architect system, Abbott, North Chicago).
HCMV-specific antibody was detected using a commercial kit (Architect CMV IgM 6C16, Abbott, Sligo, Ireland) according to the manufacturer's instructions [ 20].
Concentrations of E2 and FSH were determined by conventional chemiluminescent microparticle immunoassay using the commercial kits Architect Estradiol and Architect FSH from Abbot Laboratories (Abbott Park, IL, USA), respectively, according to the manufacturer's guidelines.
Plasma HCV-coreAg quantification was performed using a commercial chemiluminescent microparticle immunoassay (CMIA) (ARCHITECT HCV Ag Reagent Kit, Abbott Diagnostics, Abbott Park, USA) with a detection limit of 3 fmol/L, according to the manufacturer's instructions.
The app was architected with a new software development kit that was launched at SXSW.
Serum CA125 values in all samples were determined by the clinical laboratory at the Spedali Civili di Brescia, Italy, using the Architect CA125 II chemiluminescent two-step immunoassay kit (Abbott Diagnostics, Abbott Park, IL, USA) following the manufacturer's protocol.
Serum CA125 values were determined by the clinical laboratory at the Spedali Civili di Brescia, Italy using the Architect CA125 II chemiluminescent two step immunoassay kit (Abbott Diagnostics, Abbott Park, IL, USA), following the manufacturer's protocol.
Serum active B12, s-Fol, and ery-Fol concentrations were determined using the relevant Abbott Microparticle Enzyme Immunoassay (MEIA) kits (Holotranscobalamin-Active-B12 and Architect Folate, Abbott Laboratories, Abbott Park, IL, USA) on Architect analyser (Abbott).
